A potential mechanism for the synergistic effect of combining concurrent immunotherapy and SRS is the abscopal effect, in which tumor neoantigens are generated by radiation and are subsequently absorbed by antigen-presenting cells (APCs) that then activate CD8+ T cells (60–63). The gene discussed is CD8A; the disease is neoplasm.